手機版
化工儀器網手機版
化工儀器網小程序
官方微信
公眾號：chem17
掃碼關注視頻號
資料簡介
Virogen 生物技術公司是一家在生物科研和生物制藥領域具有重要影響力的企業。在業務方面，Virogen 專注于為研究和診斷市場提供各類抗體、抗原及相關實驗室設備。其產品種類豐富，涵蓋多個研究領域。在傳染病研究方面，提供用于乙肝檢測的重組乙肝核心抗原，該抗原從大腸桿菌中純化獲得，可用于抗體捕獲，貨號未明確在文檔中特殊標注；還有針對多種病毒的抗原和抗體產品，如新冠病毒相關的多個抗原產品，像冠狀病毒 19 膜 - 包膜抗原（貨號：00225 - V）、冠狀病毒 19 核衣殼蛋白（貨號：00221 - V）、冠狀病毒 19 刺突（C）抗原（貨號：00223 - V）等，為新冠病毒相關研究提供了有力工具。針對其他病毒，如流感病毒、單純皰疹病毒（HSV）等也有相應的抗原產品，HSV（皰疹病毒）gG 重組抗原（貨號：1140 - V）。在細胞相關研究中，有單鏈抗 CD 系列抗體，像單鏈抗 CD20 抗體（貨號：1152 - V）、單鏈抗 CD16 重組抗體（貨號：1151 - V）、單鏈抗 CD3 重組抗體（貨號：1150 - V） ，可用于細胞免疫等研究方向。此外，公司還提供如抗半胱氨酸單克隆抗體（貨號：102 - A）、抗麥角硫因多克隆抗體（貨號：105 - A）、抗谷胱甘肽單克隆抗體（貨號：101 - A、101 - A - 250、101 - A - 500）等多種特色抗體產品，滿足不同科研需求。
除了標準產品銷售，Virogen 還具備定制服務能力，其專家團隊能夠與客戶緊密合作，優化蛋白質純化方案，滿足客戶個性化的科研需求。在發展歷程中，Virogen 不斷拓展業務版圖，積極與各方開展合作。2025 年，公司與美國成長型投行 Lake Street Capital Markets 達成戰略合作，借助對方的資源和專業能力，開展私募融資，加速核心產品的臨床推進和商業化布局。同時，Virogen 還與藥明生物合作，委托藥明生物為其創新藥物 VG712 提供生產相關服務，共同推動藥物上市。這些合作充分展示了 Virogen 在產業協同發展方面的積極態度和強大實力，也為其未來在生物科研和生物制藥領域的持續發展奠定了堅實基礎。
特別告知：為保證產品質量與良好性能，所以在購買相應產品的同時我司會收取一定量的運輸費用！！！本次報價有效時間為2025年6月26日---2025年12月14日。
（*此為部分產品價格,完整價格請下載文件）
貨號 | 品名 | 規格 | 價格 | 品牌 |
00211-V-1mg | HHV-4 recombinant p18 antigen Region: 1-119aa | 1mg/vial | 20000.00 | Virogen |
00212-V-1mg | HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa | 1mg/vial | 20000.00 | Virogen |
00213-V-1mg | HHV-4 recombinant EA antigen. Region: 306-390aa | 1mg/vial | 20000.00 | Virogen |
00167-V-1mg | HDV Ag recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00214-V-1mg | Tick-born encephalitis virus gE recombinant antigen | 1mg/vial | 20000.00 | Virogen |
01005-V-1mg | Chlamydia trachomatis PDP3-D, Full length recombinant | 1mg/vial | 20000.00 | Virogen |
01011-V-1mg | Chlamydia trachomatis MOMP Recombinant antigen with out transmembrane domain. | 1mg/vial | 20000.00 | Virogen |
00206-V-1mg | Toxoplasma gondii MIC 3 recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00207-V-1mg | Toxoplasma gondii P24 (GRA1) recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00208-V-1mg | Toxoplasma gondii P29 (GRA7) recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00209-V-1mg | Toxoplasma gondii P30 (SAG1) recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00111-V-1mg | HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa | 1mg/vial | 20000.00 | Virogen |
00112-V-1mg | HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa | 1mg/vial | 20000.00 | Virogen |
00113-V-1mg | HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa | 1mg/vial | 20000.00 | Virogen |
00114-V-1mg | HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa | 1mg/vial | 20000.00 | Virogen |
00168-V-1mg | HIV-1 p17/24/gp120-gp41 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00169-V-1mg | HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. | 1mg/vial | 20000.00 | Virogen |
00170-V-1mg | HIV-1 gp41 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00171-V-1mg | HIV-1 gp41 Long recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00172-V-1mg | HIV-1 p17-p24 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00173-V-1mg | HIV-2 gp32 recombinant antigen. . | 1mg/vial | 20000.00 | Virogen |
00174-V-1mg | HIV-1 p24 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00175-V-1mg | HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. | 1mg/vial | 20000.00 | Virogen |
00176-V-1mg | HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. | 1mg/vial | 20000.00 | Virogen |
00177-V-1mg | HIV 1 p24 core recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00178-V-1mg | HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. | 1mg/vial | 20000.00 | Virogen |
00179-V-1mg | HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. | 1mg/vial | 20000.00 | Virogen |
00110-V-1mg | HIV-1 tat recombinant antigen full length 15 kDa | 1mg/vial | 20000.00 | Virogen |
00180-V-1mg | HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. | 1mg/vial | 20000.00 | Virogen |
00198-V-1mg | HIV-1 reverse transcriptase recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00199-V-1mg | HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). | 1mg/vial | 20000.00 | Virogen |
00115-V-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa | 1mg/vial | 20000.00 | Virogen |
00115-V-B-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. | 1mg/vial | 20000.00 | Virogen |
00115-V-F-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. | 1mg/vial | 20000.00 | Virogen |
00115-V-R-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. | 1mg/vial | 20000.00 | Virogen |
00116-V-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. | 1mg/vial | 20000.00 | Virogen |
00116-V-B-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. | 1mg/vial | 20000.00 | Virogen |
00116-V-F-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. | 1mg/vial | 20000.00 | Virogen |
00116-V-R-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. | 1mg/vial | 20000.00 | Virogen |
00117-V-1mg | HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa | 1mg/vial | 20000.00 | Virogen |
00150-V-1mg | HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a | 1mg/vial | 20000.00 | Virogen |
00151-V-1mg | HCV core 24 antigen. | 1mg/vial | 20000.00 | Virogen |
00152-V-1mg | HCV core recombinant antigen a.a.105-302 | 1mg/vial | 20000.00 | Virogen |
00153-V-1mg | HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a | 1mg/vial | 20000.00 | Virogen |
00154-V-1mg | HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 | 1mg/vial | 20000.00 | Virogen |
00155-V-1mg | HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. | 1mg/vial | 20000.00 | Virogen |
00156-V-1mg | HCV NS4 1916-1947aa recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00157-V-1mg | HCV NS5 2061-2302aa recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00158-V-1mg | HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. | 1mg/vial | 20000.00 | Virogen |
00120-V-1mg | HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa | 1mg/vial | 20000.00 | Virogen |
00121-V-1mg | HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa | 1mg/vial | 20000.00 | Virogen |
00122-V-1mg | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant | 1mg/vial | 20000.00 | Virogen |
00123-V-1mg | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity | 1mg/vial | 20000.00 | Virogen |
00124-V-1mg | HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant | 1mg/vial | 20000.00 | Virogen |
00131-V-1mg | HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. | 1mg/vial | 20000.00 | Virogen |
00132-V-1mg | HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. | 1mg/vial | 20000.00 | Virogen |
00133-V-1mg | HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. | 1mg/vial | 20000.00 | Virogen |
00141-V-1mg | T. Pallidum recombinant antigen p15 (full length) | 1mg/vial | 20000.00 | Virogen |
00142-V-1mg | T. Pallidum recombinant antigen p17 (full length) | 1mg/vial | 20000.00 | Virogen |
00143-V-1mg | T. Pallidum recombinant antigen p45 (full length) | 1mg/vial | 20000.00 | Virogen |
00144-V-1mg | T. Pallidum recombinant antigen TmpA (full length) | 1mg/vial | 20000.00 | Virogen |
00185-V-1mg | CMV Pp65 (UL83) recombinant antigen , full length | 1mg/vial | 20000.00 | Virogen |
00188-V-1mg | CMV Pp65 (UL83) recombinant antigen a.a. 297-510 | 1mg/vial | 20000.00 | Virogen |
00189-V-1mg | CMV Pp52 (UL44) recombinant antigen a.a. 271-428 | 1mg/vial | 20000.00 | Virogen |
00187-V-1mg | CMV gB-AD1 (UL55) recombinant antigen a.a. 549-645 | 1mg/vial | 20000.00 | Virogen |
00186-V-1mg | CMV Pp150 recombinant antigen a.a. 426-606 | 1mg/vial | 20000.00 | Virogen |
00159-V-1mg | HAV VP1-P2A recombinant antigen a.a. 722-830. | 1mg/vial | 20000.00 | Virogen |
00160-V-1mg | HAV VP4-VP2 recombinant antigen a.a. 55-164. | 1mg/vial | 20000.00 | Virogen |
00161-V-1mg | HAV P2C-P3A recombinant antigen a.a. 1492-1606. | 1mg/vial | 20000.00 | Virogen |
00162-V-1mg | HAV P3C recombinant antigen a.a. 1643-1743. | 1mg/vial | 20000.00 | Virogen |
00163-V-1mg | HAV VP3 recombinant antigen a.a. 304-415. | 1mg/vial | 20000.00 | Virogen |
00164-V-1mg | HAV VP1-P2A recombinant antigen a.a. 669-782. | 1mg/vial | 20000.00 | Virogen |
00165-V-1mg | HAV HAV P2C recombinant antigen a.a. 1121-1234. | 1mg/vial | 20000.00 | Virogen |
00166-V-1mg | HAV P2C-P3A recombinant antigen a.a. 1392-1521. | 1mg/vial | 20000.00 | Virogen |
00181-V-1mg | HSV-1 gD recombinant antigen a.a. 266-394. | 1mg/vial | 20000.00 | Virogen |
00182-V-1mg | HSV-2 gD recombinant antigen a.a. 266-394. | 1mg/vial | 20000.00 | Virogen |
00183-V-1mg | HSV-2 gD recombinant antigen a.a. 525-578. | 1mg/vial | 20000.00 | Virogen |
00184-V-1mg | HSV-1 gD recombinant antigen a.a. 84-175. | 1mg/vial | 20000.00 | Virogen |
1131-V-1mg | HSV-2 gB recombinant antigen | 1mg/vial | 20000.00 | Virogen |
1140-V-1mg | E. coli recombinant HSV II gG antigen. Immunodominant Region: a.a. 525-578 | 1mg/vial | 20000.00 | Virogen |
00203-V-1mg | HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. | 1mg/vial | 20000.00 | Virogen |
00204-V-1mg | HLTV-I p24 core recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00205-V-1mg | HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. | 1mg/vial | 20000.00 | Virogen |
00700-V-1mg | HTLV-1 gp21 recombinant protein | 1mg/vial | 20000.00 | Virogen |
00701-V-1mg | HTLV-1 gp46 recombinant protein | 1mg/vial | 20000.00 | Virogen |
00215-V-1mg | Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. | 1mg/vial | 20000.00 | Virogen |
00216-V-1mg | Rubella virus E2 recombinant antigen a.a. 31-105. | 1mg/vial | 20000.00 | Virogen |
00217-V-1mg | Rubella virus capsid (C) recombinant antigen a.a. 1-123. | 1mg/vial | 20000.00 | Virogen |
00191-V-1mg | SARS-Associated Coronavirus E recombinant antigen a.a. 1-76. | 1mg/vial | 20000.00 | Virogen |
00192-V-1mg | SARS-Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1-49. | 1mg/vial | 20000.00 | Virogen |
00193-V-1mg | SARS-Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340-390. | 1mg/vial | 20000.00 | Virogen |
00194-V-1mg | SARS-Associated Coronavirus M recombinant antigen a.a. 182-216. | 1mg/vial | 20000.00 | Virogen |
00195-V-1mg | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. | 1mg/vial | 20000.00 | Virogen |
00196-V-1mg | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. | 1mg/vial | 20000.00 | Virogen |
00197-V-1mg | SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. | 1mg/vial | 20000.00 | Virogen |
00200-V-1mg | VZV gE recombinant antigen a.a. 48-135. | 1mg/vial | 20000.00 | Virogen |
00201-V-1mg | VZV ORF9 recombinant antigen a.a. 6-28/76-100. | 1mg/vial | 20000.00 | Virogen |
00202-V-1mg | VZV ORF26 recombinant antigen a.a. 9-33/184-208. | 1mg/vial | 20000.00 | Virogen |
00401-V-1mg | West Nile Virus Envelope recombinant antigen-Immunodominant region | 1mg/vial | 20000.00 | Virogen |
00402-V-1mg | West Nile Virus Pre-M recombinant antigen-Immunodominant region | 1mg/vial | 20000.00 | Virogen |
00403-V-1mg | West Nile Virus Envelope full length recombinant antigen 42 kDa region | 1mg/vial | 20000.00 | Virogen |
00345-V-1mg | Zika Virus ENV -NS1 fusion antigen 54 kDa | 1mg/vial | 20000.00 | Virogen |
00346-V-1mg | Zika Virus NS1 antigen 34 kDa | 1mg/vial | 20000.00 | Virogen |
00347-V-1mg | H. pylori CogA antigen 34 kDa | 1mg/vial | 20000.00 | Virogen |
00321-V-1mg | Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 | 1mg/vial | 20000.00 | Virogen |
1170-V-1mg | Human Endogenous Retrovirus Envelope antigen 48 kDa | 1mg/vial | 20000.00 | Virogen |
3001-V-1mg | Prostatic pacid hosphatase - full length (human) | 1mg/vial | 20000.00 | Virogen |
3002-V-1mg | Ovine Prolactin | 1mg/vial | 20000.00 | Virogen |
00820-V-1mg | MPXV A29 (recombinant), partial., a.a. 1-110. pI/Mw: 6.44 / 13382.09 | 1mg/vial | 20000.00 | Virogen |
00821-V-1mg | MPXV A27 (recombinant), partial., a.a. 1-110. MW: ~14 kDa | 1mg/vial | 20000.00 | Virogen |
00900-V-1mg | Phospholipase A2 P00630 Bee Venom Recombinant Protein | 1mg/vial | 20000.00 | Virogen |
00901-V-1mg | Soy Bean p34 Recombinant protein | 1mg/vial | 20000.00 | Virogen |
900-V-1mg | Dermatophagoides farina Der F1 antigen (recombinant). Full length. Non enzymatically active. | 1mg/vial | 20000.00 | Virogen |
901-V-1mg | Dermatophagoides pteronyssinus Der P1 antigen . Full length. Non enzymatically active. | 1mg/vial | 20000.00 | Virogen |
012-A-1mg | anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
013-A-1mg | anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
014-A-1mg | anti-HIV-1 p17 IgG1 (monoclonal) Produced against a recombinant protein | 1mg/vial | 20000.00 | Virogen |
0114-A-1mg | anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
015-A-1mg | anti-HIV-1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
016-A-1mg | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
017-A-1mg | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
018-A-1mg | anti-HCV NS4 IgG2a (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
020-A-1mg | anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate | 1mg/vial | 20000.00 | Virogen |
021-A-1mg | anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. | 1mg/vial | 20000.00 | Virogen |
022-A-1mg | anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. | 1mg/vial | 20000.00 | Virogen |
023-A-1mg | anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. | 1mg/vial | 20000.00 | Virogen |
024-A-1mg | anti-HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. | 1mg/vial | 20000.00 | Virogen |
025-A-1mg | anti-Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus | 1mg/vial | 20000.00 | Virogen |
026-A-1mg | anti-Adenovirus C11 IgG2a (monoclonal) Produced against purified Ad7 virus | 1mg/vial | 20000.00 | Virogen |
027-A-1mg | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 1mg/vial | 20000.00 | Virogen |
028-A-1mg | anti-TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. | 1mg/vial | 20000.00 | Virogen |
030-A-1mg | anti-HBcAg core IgM (monoclonal) Produced against recombinant HBcAg core antigen. | 1mg/vial | 20000.00 | Virogen |
031-A-1mg | anti-HBsAg pre-surface IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 1mg/vial | 20000.00 | Virogen |
032-A-1mg | anti-HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 1mg/vial | 20000.00 | Virogen |
033-A-1mg | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 70 – 80 a.a. | 1mg/vial | 20000.00 | Virogen |
034-A-1mg | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 135-140 a.a. | 1mg/vial | 20000.00 | Virogen |
035-A-1mg | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope:141-154 a.a. | 1mg/vial | 20000.00 | Virogen |
036-A-1mg | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 1-10 a.a. | 1mg/vial | 20000.00 | Virogen |
037-A-1mg | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 138- 145 a.a. | 1mg/vial | 20000.00 | Virogen |
038-A-1mg | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 130-140 a.a. | 1mg/vial | 20000.00 | Virogen |
0116-A-1mg | anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 1mg/vial | 20000.00 | Virogen |
0117-A-1mg | anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 1mg/vial | 20000.00 | Virogen |
216-A-1mg | anti-HCV core IgG1 (monoclonal)Produced against recombinant antigen | 1mg/vial | 20000.00 | Virogen |
245-A-1mg | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 | 1mg/vial | 20000.00 | Virogen |
246-A-1mg | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen | 1mg/vial | 20000.00 | Virogen |
247-A-1mg | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 | 1mg/vial | 20000.00 | Virogen |
266-A-1mg | anti-HCV NS5b rabbit (polycnonal)Produced against a recombinant protein | 1mg/vial | 20000.00 | Virogen |
199-A-1mg | anti-HCV NS5a rabbit (polycnonal) Produced against a recombinant protein | 1mg/vial | 20000.00 | Virogen |
276-A-1mg | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 1mg/vial | 20000.00 | Virogen |
010-A-1mg | anti-Rabies G antigen monoclonal antibody. Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
111-A-1mg | anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
101-A-1mg | anti-Glutathione monoclonal antibody IgG1 | 1mg/vial | 20000.00 | Virogen |
102-A-1mg | anti-Cysteine monoclonal antibody IgG1 | 1mg/vial | 24000.00 | Virogen |
105-A-1mg | anti-Ergothioneine rabbit polyclonal antibody | 1mg/vial | 24000.00 | Virogen |
041-A-1mg | anti-Thyroxine monoclonal antibody IgG2a | 1mg/vial | 24000.00 | Virogen |
011-A-1mg | anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. | 1mg/vial | 20000.00 | Virogen |
019-A-1mg | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
029-A-1mg | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
039-A-1mg | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
049-A-1mg | anti-FAS IgM (monoclonal) | 1mg/vial | 20000.00 | Virogen |
059-A-1mg | anti-SLAM anti-CDw150 IgG2a (monoclonal) Produced against an activated B cell line. | 1mg/vial | 20000.00 | Virogen |
069-A-1mg | anti-CD37 IgG2b (monoclonal) Produced against a B cell line. | 1mg/vial | 20000.00 | Virogen |
079-A-1mg | anti-Nuclear Antigen (Proliferating Cells) IgM (monoclonal) Produced against a proliferating Harvey cell line. | 1mg/vial | 20000.00 | Virogen |
066-A-1mg | anti-p53, clone BP53-12 | 1mg/vial | 20000.00 | Virogen |
060-A-1mg | anti-CD3 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
061-A-1mg | anti-CD4 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
062-A-1mg | anti-CD8 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
063-A-1mg | anti-CD16 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
064-A-1mg | anti-CD20 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
065-A-1mg | anti-CD22 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
067-A-1mg | anti-CD45 RA IgG2 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
068-A-1mg | anti-CD54 IgG2b-k monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
071-A-1mg | anti-CD19 IgG1 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
089-A-1mg | anti-CD66e IgG1 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
501-A-1mg | anti-CD3 T-cell | 1mg/vial | 20000.00 | Virogen |
502-A-1mg | anti-CD4 T helper cells | 1mg/vial | 20000.00 | Virogen |
503-A-1mg | anti-CD5 All T-cells | 1mg/vial | 20000.00 | Virogen |
504-A -1mg | anti-CD7 All T-cells | 1mg/vial | 20000.00 | Virogen |
505-A -1mg | anti-CD8 T cytotoxic/supressor cells | 1mg/vial | 20000.00 | Virogen |
506-A -1mg | anti-CD10 Lymphoblasts | 1mg/vial | 20000.00 | Virogen |
507-A -1mg | anti-CD16 NK-cells, monocytes, granulocytes | 1mg/vial | 20000.00 | Virogen |
508-A -1mg | anti-CD18 Leucocytes | 1mg/vial | 20000.00 | Virogen |
509-A-1mg | anti-CD20 B-lymphocytes | 1mg/vial | 20000.00 | Virogen |
510-A-1mg | anti-CD22 B-lymphocytes | 1mg/vial | 20000.00 | Virogen |
511-A-1mg | anti-CD25 IL-2 receptor expressed on activated T and B cells | 1mg/vial | 20000.00 | Virogen |
512-A-1mg | anti-CD26 Activated T, B lymphocytes and macrophages | 1mg/vial | 20000.00 | Virogen |
513-A-1mg | anti-CD34 Hematopoietic precursor cells | 1mg/vial | 20000.00 | Virogen |
514-A-1mg | anti-CD38 Hematopoietic precursors, thymocytes, activated T-cells, plasma cells | 1mg/vial | 20000.00 | Virogen |
515-A-1mg | anti-CD45 Leukocytes | 1mg/vial | 20000.00 | Virogen |
516-A-1mg | anti-CD45 RA B-cells, T-cells, NK-cells | 1mg/vial | 20000.00 | Virogen |
517-A-1mg | anti-ICAM-3, Leukocytes | 1mg/vial | 20000.00 | Virogen |
518-A-1mg | anti-Transferrin receptor on activated T-B-, cells | 1mg/vial | 20000.00 | Virogen |
519-A-1mg | anti-FAS antigen | 1mg/vial | 20000.00 | Virogen |
520-A-1mg | anti-HLA-DR | 1mg/vial | 20000.00 | Virogen |
521-A-1mg | anti-HLA-ABC on all Leukocytes | 1mg/vial | 20000.00 | Virogen |
522-A-1mg | anti-IgM Heavy chain expressed on B cells | 1mg/vial | 20000.00 | Virogen |
523-A-1mg | anti-Cortical thymocytes | 1mg/vial | 20000.00 | Virogen |
131-A-1mg | anti-RhoD human antigen IgG1 | 1mg/vial | 20000.00 | Virogen |
132-A-1mg | anti-A1, A2 human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
133-A-1mg | anti-A1, A2, A3 human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
134-A-1mg | anti-B human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
135-A-1mg | anti-AB human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
136-A-1mg | anti-Rh(o)D human antigen IgM | 1mg/vial | 20000.00 | Virogen |
137-A-1mg | anti-Rh(o)D and Rh(o)Dii human Rhesus system antigen IgG1 | 1mg/vial | 20000.00 | Virogen |
138-A-1mg | anti-RhoC human Rhesus system antigen IgM | 1mg/vial | 20000.00 | Virogen |
139-A-1mg | anti-A1, A2 human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
140-A-1mg | anti-B human blood group antigen IgM | 1mg/vial | 20000.00 | Virogen |
141-A-1mg | anti-H n/ab human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
142-A-1mg | anti-H ab human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
143-A-1mg | anti-H inh human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
144-A-1mg | anti-M human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
145-A-1mg | anti-N human blood antigen Ig2b | 1mg/vial | 20000.00 | Virogen |
146-A-1mg | Antiglobulin (COOMBS) Rabbit polyclonal | 1mg/vial | 20000.00 | Virogen |
相關產品
免責聲明
- 凡本網注明“來源：化工儀器網”的所有作品，均為浙江興旺寶明通網絡有限公司-化工儀器網合法擁有版權或有權使用的作品，未經本網授權不得轉載、摘編或利用其他方式使用上述作品。已經本網授權使用作品的，應在授權范圍內使用，并注明“來源：化工儀器網”。違反上述聲明者，本網將追究其相關法律責任。
- 本網轉載并注明自其他來源（非化工儀器網）的作品，目的在于傳遞更多信息，并不代表本網贊同其觀點和對其真實性負責，不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網站或個人從本網轉載時，必須保留本網注明的作品第一來源，并自負版權等法律責任。
- 如涉及作品內容、版權等問題，請在作品發表之日起一周內與本網聯系，否則視為放棄相關權利。
采購中心